About NeuropsychiatrieHK, s.r.o.
Clinical Trials at NeuropsychiatrieHK, s.r.o.
During the past decade, NeuropsychiatrieHK, s.r.o. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 2 clinical trials were completed, i.e. on
average, 13.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "NeuropsychiatrieHK, s.r.o." #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "ACADIA Pharmaceuticals Inc." with 2 trials
sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored, "Algiax Pharmaceuticals GmbH" with 1 trials sponsored and "Green Valley (Shanghai) Pharmaceuticals Co., Ltd."
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "NeuropsychiatrieHK, s.r.o."
#1 collaborator was "ADIR Association" with 1 trials as a collaborator and "FGK Clinical Research GmbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at NeuropsychiatrieHK, s.r.o.
According to Clinical.Site data, the most researched conditions in "NeuropsychiatrieHK, s.r.o." are
"Depressive Disorder, Major" (5 trials), "Schizophrenia" (3 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Major Depressive Disorder" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "NeuropsychiatrieHK, s.r.o." in a lesser frequency.
Clinical Trials Intervention Types at NeuropsychiatrieHK, s.r.o.
Most popular intervention types in "NeuropsychiatrieHK, s.r.o." are "Drug" (15 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "AVP-786" (2 trials), "Aticaprant" (2 trials), "Pimavanserin" (2 trials) and "SSRI/SNRI" (2 trials). Other intervention names were less common.
Clinical Trials Genders at NeuropsychiatrieHK, s.r.o.
The vast majority of trials in "NeuropsychiatrieHK, s.r.o." are
15 trials for "All" genders.
Clinical Trials Status at NeuropsychiatrieHK, s.r.o.
Currently, there are NaN active trials in "NeuropsychiatrieHK, s.r.o.".
undefined are not yet recruiting,
8 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in NeuropsychiatrieHK, s.r.o.,
1 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in NeuropsychiatrieHK, s.r.o., 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".